ScandiDos AB (OSTO:SDOS) ROCE %: 1.87% (As of Apr. 2026)

What is ScandiDos AB ROCE %?

ScandiDos AB OSTO:SDOS +0.60% 47 ROCE % is 1.87% as of Apr. 2026. GuruFocus rates OSTO:SDOS with a GF Score™ of 47/100 and a GF Value™ of kr1.15 (Modestly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. ScandiDos AB's annualized ROCE % for the quarter that ended in Apr. 2026 was 1.87%.

ScandiDos AB (OSTO:SDOS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

ScandiDos AB ROCE % Related Terms

ScandiDos AB ROCE % Historical Data

* Premium members only.

The historical data trend for ScandiDos AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ScandiDos AB ROCE % Chart

ScandiDos AB Annual Data

Trend

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Apr25

Apr26

ROCE %

Get a 7-Day Free Trial

-17.25

-19.74

-28.72

2.38

-6.64

ScandiDos AB Quarterly Data
	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25	Jul25	Oct25	Jan26	Apr26
ROCE %	Get a 7-Day Free Trial															-2.80	-18.70	3.27	-12.51	1.87

47GF Score

ScandiDos AB OSTO:SDOS

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

ScandiDos AB ROCE % Calculation

ScandiDos AB's annualized ROCE % for the fiscal year that ended in Apr. 2026 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Apr. 2026 )		(A: Apr. 2025 )		(A: Apr. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Apr. 2026 )		(A: Apr. 2025 )		(A: Apr. 2026 )
	=	-2.977	/	( ( (73.379 - 25.926)	+	(65.974 - 23.704) )	/ 2 )
	=	-2.977	/	( (47.453	+	42.27)	/ 2 )
	=	-2.977	/	44.8615
	=	-6.64 %

ScandiDos AB's ROCE % of for the quarter that ended in Apr. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Apr. 2026 )		(Q: Jan. 2026 )		(Q: Apr. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Apr. 2026 )		(Q: Jan. 2026 )		(Q: Apr. 2026 )
	=	0.788	/	( ( (68.089 - 26.26)	+	(65.974 - 23.704) )	/ 2 )
	=	0.788	/	( ( 41.829	+	42.27 )	/ 2 )
	=	0.788	/	42.0495
	=	1.87 %

(1) Note: The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 1.87% mean?

ScandiDos AB (OSTO:SDOS) has a ROCE % of 1.87% as of Apr. 2026.

Is ScandiDos AB's ROCE % too high?

ScandiDos AB's current ROCE % is 1.87%. The Medical Devices & Instruments industry median ROCE % is 2.23. ScandiDos AB's value of 1.87% is 16.1% below this industry median. Overall, ScandiDos AB has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does ScandiDos AB's ROCE % compare to ABT and SYK?

ScandiDos AB's ROCE % of 1.87% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. ScandiDos AB's value of 1.87% is 16.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Devices & Instruments company?

The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ScandiDos AB's current ROCE % of 1.87% is 16.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ScandiDos AB's current ROCE % is 1.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is ScandiDos AB stock overvalued right now?

Based on GuruFocus' analysis, ScandiDos AB (OSTO:SDOS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr1.15, compared to a current price of kr0.84 — trading 27.4% below its estimated fair value. The current ROCE % is 1.87% and 16.1% below the Medical Devices & Instruments industry median of 2.23. ScandiDos AB's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For ScandiDos AB (OSTO:SDOS), the current ROCE % is 1.87% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ScandiDos AB (OSTO:SDOS) Overvalued in 2026?

Based on GuruFocus' analysis, ScandiDos AB stock appears to be undervalued. The current stock price of kr0.84 is trading 27.4% below its estimated GF Value™ of kr1.15. GuruFocus considers ScandiDos AB to be Modestly Undervalued.

Key valuation signals for OSTO:SDOS:

ROCE %: 1.87%
GF Value™: kr1.15 vs. price of kr0.84 (27.4% below fair value)
GF Score™: 47/100 with 4 warning signs
Industry Position: 16.1% below the Medical Devices & Instruments median

No single metric tells the full story. See the OSTO:SDOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ScandiDos AB Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OSTO:SPEC OSTO:QLIFE XSAT:REDS XSAT:BIBB XSAT:POLAR OSTO:NEOLA XSAT:VSD B OSTO:PERP B XSAT:PEXA B XSAT:ZENI ABT SYK MDT BSX EW XTER:SHL DXCM GEHC SZSE:300760 XAMS:PHIA

Address Uppsala Science Park, Uppsala, SWE, SE-751 83

Website https://www.scandidos.com

ScandiDos AB is engaged in providing radiation therapy for cancer. Its product, Delta4 Phantom+, and its various hardware and software options are at the heart of everything ScandiDos does, from product development and production to marketing, sales, and customer support. With Delta4 HexaMotion ScandiDos has successfully developed a motion platform that recreates the movement of the tumor in six dimensions and independently simulates the patient's breathing movement.

47GF Score

Get the complete analysis for OSTO:SDOS

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.84

Price

kr1.15

GF Value

View OSTO:SDOS Analysis

See ROCE % data for all stocks →